| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunic, Inc. (IMUX) has 12 insiders with recent SEC Form 4 filings, including 15 buys and 0 sells. IMUX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.72M | $20.00M | - | |
| CFO | 560.0K | $6.51M | - | |
| Other | 330.0K | $3.84M | - | |
| COO | 330.0K | $3.84M | - | |
| Other | 315.0K | $3.66M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2017 | Satter Muneer A58 | Director, 10% Owner | Buy | 50,000 | $3.53 | $176,615.00 | +0.5% | |
| Jun 14, 2017 | Dunn John Michael | General Counsel And Secretary | Buy | 2,500 | $3.09 | $7,724.46 | +13.2% | |
| Jun 14, 2017 | Winters Terence E. | Co-chairman And CEO | Buy | 10,000 | $3.10 | $30,981.00 | +5.4% | |
| Jun 14, 2017 | Satter Muneer A58 | Director, 10% Owner | Buy | 20,000 | $3.07 | $61,319.00 | - | |
| Jun 13, 2017 | Bienaime Jean Jacques68 | Director | Buy | 16,000 | $3.00 | $48,068.80 | +40.9% | |
| Jun 12, 2017 | Satter Muneer A58 | Director, 10% Owner | Buy | 30,000 | $3.11 | $93,306.00 | - | |
| Jun 9, 2017 | Ashley Robert A. | Chief Technical Officer, EVP | Buy | 2,000 | $3.18 | $6,360.00 | New | |
| Jun 8, 2017 | Nash Duane | President | Buy | 3,900 | $3.12 | $12,182.04 | +90.2% | |
| Jun 7, 2017 | Satter Muneer A58 | Director, 10% Owner | Buy | 20,000 | $3.20 | $64,014.00 | - | |
| Mar 27, 2017 | Satter Muneer A58 | Director, 10% Owner | Buy | 3,750,000 | $4.00 | $15,000,000.00 | +52.6% |